肿瘤抑制因子
白血病抑制因子受体
糖蛋白130
白血病抑制因子
受体
生物
细胞生物学
细胞因子受体
白细胞介素-21受体
普通伽马链
细胞因子
信号转导
白细胞介素-6受体
分子生物学
白细胞介素6
免疫学
生物化学
车站3
作者
Johannes Drechsler,Joachim Grötzinger,Heike M. Hermanns
出处
期刊:PLOS ONE
[Public Library of Science]
日期:2012-08-22
卷期号:7 (8): e43155-e43155
被引量:49
标识
DOI:10.1371/journal.pone.0043155
摘要
Evaluation of a pathophysiological role of the interleukin-6-type cytokine oncostatin M (OSM) for human diseases has been complicated by the fact that mouse models of diseases targeting either OSM or the OSM receptor (OSMR) complex cannot fully reflect the human situation. This is due to earlier findings that human OSM utilizes two receptor complexes, glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR) (type I) and gp130/OSMR (type II), both with wide expression profiles. Murine OSM on the other hand only binds to the gp130/OSMR (type II) receptor complex with high affinity. Here, we characterize the receptor usage for rat OSM. Using different experimental approaches (knock-down of the OSMR expression by RNA interference, blocking of the LIFR by LIF-05, an antagonistic LIF variant and stably transfected Ba/F3 cells) we can clearly show that rat OSM surprisingly utilizes both, the type I and type II receptor complex, therefore mimicking the human situation. Furthermore, it displays cross-species activities and stimulates cells of human as well as murine origin. Its signaling capacities closely mimic those of human OSM in cell types of different origin in the way that strong activation of the Jak/STAT, the MAP kinase as well as the PI3K/Akt pathways can be observed. Therefore, rat disease models would allow evaluation of the relevance of OSM for human biology.
科研通智能强力驱动
Strongly Powered by AbleSci AI